Agenda & Dial-in Instructions
RTS,S Phase 2b Pediatric Clinical Trial
Audio Conference Press Briefing
I. Logistical Details and Introduction
II. Presentations (listed in the order they will speak):
- Pedro Alonso, M.D., Ph.D., lead author, principal investigator, and
head of the Center for International Health at the Hospital Clinic of
the University of Barcelona
- Jean Stephenne, President and General Manager, GSK Biologicals
- Melinda Moree, Ph.D., Director, Malaria Vaccine Initiative, PATH
- Regina Rabinovich, M.D., Director, Infectious Diseases, Global Health
Program, Bill & Melinda Gates Foundation
III. Questions and Answer Period
Also present to respond to questions will be the following:
- Ripley Ballou, M.D., Vice President, Clinical Development, GSK Biologicals
- Joe Cohen, Ph.D., Director, Emerging Diseases, HIV & Therapeutic
Vaccines R&D, GSK Biologicals
- Filip Dubovsky, M.D., M.P.H., F.A.A.P, Scientific Director, Malaria
Vaccine Initiative, PATH
Dial-in and Playback Instructions
Media around the world can access the audioconference by calling +44
207 081 9432 at 10:00 a.m. UK Time//11:00 a.m. Central Europe Summer
Time. A replay of the call will be available from 11:00 a.m. UK time on
14th October for 24 hours and can be accessed by dialing +44 207 081 9440
(US access +1 800 897 7608) followed by the code 944793 and the recording
ID 358348.
This page displays best in a browser that supports current web standards, but all content is accessible via any web device.
Site Map | Home | Contact
About | Malaria & Malaria Vaccines | Downloads & Links
info@MalariaVaccine.org
